Paydirt
KP
Insider

Karah Herdman Parschauer

EVP and Chief Legal Officer

Karah Herdman Parschauer (EVP and Chief Legal Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $185K of RARE (8,135 sh × $22.80, as filed), executed Mar 2.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$314K
shares × price, as filed
Last traded
Mar 6
Filed Mar 10

Median ADV $57.1M across their filed names

Open performance→
Volume by month
$708K$354K$0Oct 2024Apr 2025Oct 2025Apr 2026Mar 2025 · sells $708KMar 2026 · sells $314K
Buys $0 Sells $1.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
RARE Ultragenyx Pharmaceutical Inc. RARE · 0 buys · 3 sells 3 filings EOLS Evolus, Inc. EOLS · 0 buys · 1 sell 1 filing
Recent filings
RARESALE Ultragenyx Pharmaceutical Inc. View filing → $129K
6,018 sh × $21.40
Exec Mar 6
Filed Mar 10 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $185K
8,135 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET EOLSSALE Evolus, Inc. View filing → $167K
12,888 sh × $12.99
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. View filing → $541K
12,846 sh × $42.10
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET